BBI
MRK icon

Baxter Bros Inc’s Merck MRK Stock Holding History

Baxter Bros Inc’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
10,391
+824
+9% +$96.4K 0.15% 84
2026
Q1 		$1.15M Sell
9,567
-300
-3% -$34.6K 0.14% 85
2025
Q4 		$1.04M Sell
9,867
-60
-0.6% -$5.63K 0.12% 88
2025
Q3 		$833K Sell
9,927
-645
-6% -$53.1K 0.1% 96
2025
Q2 		$837K Sell
10,572
-1,000
-9% -$79.5K 0.1% 91
2025
Q1 		$1.04M Sell
11,572
-1,992
-15% -$186K 0.14% 79
2024
Q4 		$1.35M Sell
13,564
-1,556
-10% -$160K 0.18% 77
2024
Q3 		$1.72M Sell
15,120
-1,414
-9% -$168K 0.22% 73
2024
Q2 		$2.05M Sell
16,534
-1,013
-6% -$130K 0.27% 64
2024
Q1 		$2.32M Sell
17,547
-4,854
-22% -$598K 0.3% 60
2023
Q4 		$2.44M Buy
22,401
+26
+0.1% +$2.7K 0.34% 56
2023
Q3 		$2.3M Sell
22,375
-534
-2% -$57.6K 0.35% 57
2023
Q2 		$2.64M Sell
22,909
-219
-0.9% -$24.9K 0.39% 57
2023
Q1 		$2.46M Sell
23,128
-179
-0.8% -$19.3K 0.39% 58
2022
Q4 		$2.59M Buy
23,307
+1,001
+4% +$102K 0.43% 55
2022
Q3 		$1.92M Buy
22,306
+4,891
+28% +$437K 0.34% 57
2022
Q2 		$1.59M Sell
17,415
-299
-2% -$26.5K 0.29% 63
2022
Q1 		$1.45M Buy
17,714
+71
+0.4% +$5.6K 0.22% 66
2021
Q4 		$1.35M Sell
17,643
-1,988
-10% -$158K 0.2% 69
2021
Q3 		$1.47M Sell
19,631
-954
-5% -$72.6K 0.24% 64
2021
Q2 		$1.6M Sell
20,585
-2,316
-10% -$172K 0.25% 62
2021
Q1 		$1.69M Buy
22,901
+2,456
+12% +$181K 0.29% 60
2020
Q4 		$1.6M Buy
20,445
+7,396
+57% +$566K 0.3% 58
2020
Q3 		$1.03M Buy
13,049
+2,229
+21% +$175K 0.22% 64
2020
Q2 		$798K Buy
10,820
+347
+3% +$26.1K 0.19% 66
2020
Q1 		$769K Buy
10,473
+766
+8% +$60.2K 0.2% 70
2019
Q4 		$842K Buy
9,707
+636
+7% +$52.2K 0.18% 74
2019
Q3 		$729K Sell
9,071
-47
-0.5% -$3.77K 0.17% 72
2019
Q2 		$729K Buy
9,118
+1
+0% +$77 0.17% 73
2019
Q1 		$723K Sell
9,117
-232
-2% -$17.4K 0.17% 77
2018
Q4 		$682K Buy
9,349
+338
+4% +$23.9K 0.19% 75
2018
Q3 		$610K Sell
9,011
-523
-5% -$33.3K 0.15% 83
2018
Q2 		$552K Buy
9,534
+1
+0% +$56 0.15% 82
2018
Q1 		$495K Sell
9,533
-313
-3% -$16.9K 0.14% 89
2017
Q4 		$529K Buy
9,846
+834
+9% +$46.2K 0.15% 82
2017
Q3 		$551K Buy
9,012
+1
+0% +$61 0.16% 80
2017
Q2 		$551K Buy
9,011
+1
+0% +$61 0.17% 78
2017
Q1 		$546K Buy
9,010
+1
+0% +$61 0.17% 80
2016
Q4 		$506K Sell
9,009
-1,405
-13% -$82.2K 0.16% 81
2016
Q3 		$620K Sell
10,414
-2,122
-17% -$124K 0.21% 73
2016
Q2 		$689K Buy
+12,536
New +$667K 0.24% 68
2015
Q4 		$626K Buy
12,415
+319
+3% +$16.1K 0.23% 74
2015
Q3 		$657K Hold
12,096
– – 0.24% 73
2015
Q2 		$657K Buy
12,096
+140
+1% +$7.85K 0.24% 73
2015
Q1 		$656K Buy
11,956
+421
+4% +$23.8K 0.24% 70
2014
Q4 		$625K Buy
11,535
+106
+0.9% +$5.91K 0.23% 70
2014
Q3 		$647K Buy
11,429
+185
+2% +$10.4K 0.25% 65
2014
Q2 		$621K Buy
11,244
+508
+5% +$27.7K 0.26% 63
2014
Q1 		$582K Hold
10,736
– – 0.26% 60
2013
Q4 		$513K Buy
10,736
+63
+0.6% +$2.88K 0.24% 63
2013
Q3 		$485K Sell
10,673
-26
-0.2% -$1.19K 0.27% 59
2013
Q2 		$474K Buy
+10,699
New +$478K 0.29% 55

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baxter Bros Inc's MRK Position: Q2 2026 in Review

Baxter Bros Inc increased its Merck (MRK) stake by 8.6% in Q2 2026, buying an estimated $96.4K and bringing the position to 10,391 shares worth $1.34M. The position accounts for 0.15% of the portfolio, ranked #84.

Baxter Bros Inc first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.64M in Q2 2023. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Baxter Bros Inc held 10,391 shares of Merck worth $1.34M as of Q2 2026.
  • Baxter Bros Inc bought 824 Merck shares in Q2 2026, an estimated $96.4K.
  • Merck made up 0.15% of Baxter Bros Inc's portfolio in Q2 2026, its #84 holding.
  • Baxter Bros Inc first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Baxter Bros Inc's Merck position peaked at $2.64M in Q2 2023.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Baxter Bros Inc's 13F filing for Q2 2026, filed 6 Aug 2026.